ADIM
PODD icon

Alpha DNA Investment Management’s Insulet PODD Stock Holding History

Alpha DNA Investment Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,778
Closed -$725K – 133
2024
Q4 		$725K Buy
+2,778
New +$700K 0.28% 82
2023
Q4 		– Sell
-3,304
Closed -$527K – 226
2023
Q3 		$527K Buy
+3,304
New +$740K 0.22% 128

Other funds holding PODD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Alpha DNA Investment Management's PODD Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Insulet (PODD) in Q1 2025, closing a stake of 2,778 shares — an estimated $725K sold.

Alpha DNA Investment Management first reported a position in PODD in Q3 2023 and held it in 2 quarters. The position peaked at $725K in Q4 2024. 717 funds tracked by Wall St. Rank hold PODD as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Insulet position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,778 Insulet shares in Q1 2025, an estimated $725K.
  • Alpha DNA Investment Management first reported a position in Insulet in Q3 2023 and held it in 2 quarters.
  • Alpha DNA Investment Management's Insulet position peaked at $725K in Q4 2024.
  • 717 funds tracked by Wall St. Rank held Insulet as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.